Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is iron maintenance therapy better than load and hold?

Literature DB >> 23787912

Is iron maintenance therapy better than load and hold?

Connie M Rhee, Kamyar Kalantar-Zadeh.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Iron

Year: 2013 PMID： 23787912 PMCID： PMC5831118 DOI： 10.1681/ASN.2013050456

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

17 in total

1. Administration of parenteral iron and mortality among hemodialysis patients.

Authors: Harold I Feldman; Marshall Joffe; Bruce Robinson; Jill Knauss; Borut Cizman; Wensheng Guo; Eunice Franklin-Becker; Gerald Faich
Journal: J Am Soc Nephrol Date: 2004-06 Impact factor: 10.121

Review 2. Observational studies versus randomized controlled trials: avenues to causal inference in nephrology.

Authors: Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal: Adv Chronic Kidney Dis Date: 2012-01 Impact factor: 3.620

3. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.

Authors: K Kalantar-Zadeh; B R Don; R A Rodriguez; M H Humphreys
Journal: Am J Kidney Dis Date: 2001-03 Impact factor: 8.860

4. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.

Authors: Günter Weiss; Edgar Meusburger; Gudrun Radacher; Katja Garimorth; Ulrich Neyer; Gert Mayer
Journal: Kidney Int Date: 2003-08 Impact factor: 10.612

5. Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.

Authors: Elani Streja; Csaba P Kovesdy; Sander Greenland; Joel D Kopple; Charles J McAllister; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal: Am J Kidney Dis Date: 2008-08-29 Impact factor: 8.860

6. The adverse effect of iron repletion on the course of certain infections.

Authors: M J Murray; A B Murray; M B Murray; C J Murray
Journal: Br Med J Date: 1978-10-21

Review 7. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?

Authors: Kamyar Kalantar-Zadeh; Kourosh Kalantar-Zadeh; Grace H Lee
Journal: Clin J Am Soc Nephrol Date: 2006-09 Impact factor: 8.237

8. Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload.

Authors: Y Waterlot; B Cantinieaux; C Hariga-Muller; E De Maertelaere-Laurent; J L Vanherweghem; P Fondu
Journal: Br Med J (Clin Res Ed) Date: 1985-08-24

9. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Authors: Tilman Drüeke; Véronique Witko-Sarsat; Ziad Massy; Béatrice Descamps-Latscha; Alain P Guerin; Sylvain J Marchais; Valérie Gausson; Gérard M London
Journal: Circulation Date: 2002-10-22 Impact factor: 29.690